Drug combination for treating neurodegenerative disease, such as Huntington's disease and several spinocerebellar ataxias caused by abnormal cytosine, adenine, guanine repeat expansions, comprises itraconazole and oseltamivir
	SHUKLA S; KUMAR A
	2024-12-18
专利权人	INDIAN INST TECHNOLOGY INDORE (INTE-Non-standard)
申请日期	2024-12-18
专利号	IN202421100305-A
成果简介	NOVELTY - Drug combination comprises itraconazole and oseltamivir. USE - Drug combination for treating neurodegenerative disease, such as Huntington's disease (HD) and several spinocerebellar ataxias (SCAs) caused by abnormal cytosine, adenine, guanine (CAG) repeat expansions (all claimed). No biological data given. ADVANTAGE - The drug combination exhibits ability to cross biological barriers, synergistic efficacy, improved safety profile, enhanced biological activity, tuneable pharmacokinetics, high selectivity and specificity.
IPC 分类号	A61K-031/497 ; A61K-009/14
国家	印度
专业领域	医药卫生
语种	英语
成果类型	专利
文献类型	科技成果
条目标识符	http://119.78.100.226:8889/handle/3KE4DYBR/13971
专题	中国科学院新疆生态与地理研究所
作者单位	INDIAN INST TECHNOLOGY INDORE (INTE-Non-standard)
推荐引用方式 GB/T 7714	SHUKLA S,KUMAR A. Drug combination for treating neurodegenerative disease, such as Huntington's disease and several spinocerebellar ataxias caused by abnormal cytosine, adenine, guanine repeat expansions, comprises itraconazole and oseltamivir. IN202421100305-A[P]. 2024.

条目包含的文件
条目无相关文件。

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。